Moreover, the NMOSD AQP4-Ab-negative phenotype may refer to other antigens targeted by a distinct mechanism37, as observed in the autoimmune disorder myasthenia gravis (MG) for which the acetylcholine receptor (AchR) antibody was found to be the disease’s biomarker. This evidence concerns the gene AQP4 and autoimmune disease.